List of Amlodipine Besylate drug patents

Amlodipine Besylate is owned by Synthon Pharms.

Amlodipine Besylate contains Amlodipine Besylate.

Amlodipine Besylate has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Amlodipine Besylate are:

  • US6828339

Amlodipine Besylate was authorised for market use on 27 September, 2007.

Amlodipine Besylate is available in tablet, orally disintegrating;oral dosage forms.

The generics of Amlodipine Besylate are possible to be released after 20 November, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6828339 SYNTHON PHARMS Amlodipine salt forms and processes for preparing them
Nov, 2022

(2 months ago)

Drugs and Companies using AMLODIPINE BESYLATE ingredient

Market Authorisation Date: 27 September, 2007

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in